Saudi Arabia and UAE Lead the GCC Radiopharmaceuticals Market
Saudi Arabia and the UAE are leading the GCC Radiopharmaceuticals Market, driven by ambitious healthcare transformation agendas, significant infrastructure investment, and growing cancer care capacity. Saudi Vision 2030 includes substantial investment in healthcare, including oncology centres and nuclear medicine facilities. The UAE's healthcare investment programmes and medical tourism...
0 Commentarii 0 Distribuiri 2 Views 0 previzualizare